Vertex Pharma (VRTX) June volatility elevated into data

Vertex Pharma (Nasdaq: VRTX) PDUFA date for Incivek, (hepatitis C virus treatment) is expected on May 23. May put option implied volatility is at 62, June is at 56, July at 49; compared to its six-month average of 42 according to Track Data.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• Dell Technologies (DELL) call put ratio 1 call to 1 put with a focus on expiring August options
• Broadcom (AVGO) spreader of September 220 and 360 puts